BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer Documento uri icon

  •  
  • Visão geral
  •  
  • Identidade
  •  
  • Informação adicional documento
  •  
  • Outro
  •  
  • Ver todos
  •  

tipo

  • journal article

data de publicação

  • 2020-01-01